HUAWEI DESIGN
833427
ZECHENG ELECTRONICS
837821
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Kaytune Industrial
301001
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.52
- +0.01+0.40%
Noon Break Jan 9 11:30 CST
6.63BMarket Cap-3.83P/E (TTM)
2.53High2.47Low121.07KlotVolume2.49Open2.51Pre Close30.27MTurnover0.46%Turnover RatioLossP/E (Static)2.63BShares3.2952wk High2.18P/B6.62BFloat Cap2.0152wk Low2.76Limit Up2.63BShs Float14.30Historical High2.26Limit Down2.39%Amplitude0.40Historical Low--Dividend TTM2.50Avg Price56.66KlotAsk--Div YieldTTM100Lot Size63.21KlotBid
Shenzhen Neptunus Bioengineering News
Haiwang Biotech: Legal Opinions of Beijing Deheng (Shenzhen) Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Shenzhen Haiwang Biotech Co., Ltd.
Haiwang Biotech: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Neptune Biotech: Announcement on the extension of the company\'s controlling shareholder\'s commitment to avoid competition in the same industry
Haiwang Biotech: Announcement on Additional Provisional Proposals for the 2024 Fourth Extraordinary General Meeting of Shareholders and Supplementary Notice to the Shareholders\' Meeting
Haiwang Biotech: Announcement on the Notice of Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Neptune Biotech: Announcement on cumulative lawsuits and arbitration
Neptune Biotech: Announcement on completing the registration of industrial and commercial changes
Haiwang Biotech: Announcement on not holding a shareholders\' meeting
Haiwang Biotech: Legal Opinions of Beijing Deheng (Shenzhen) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shenzhen Haiwang Biotech Co., Ltd.
Haiwang Biotech: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Neptune Biotech: General Manager Job Rules (August 2024)
Neptune Biotech: Semi-annual non-operating capital usage and other related capital transactions summary table
Neptune Biotech: Announcement on reducing registered capital and amending the company\'s articles of association
Neptune Biotech: Foreign Investment Management System (August 2024)
Neptune Biotech: 2024 Semi-Annual Financial Report
Kaiwang Biotech: Board Secretary Work System (August 2024)
Haiwang Biotech: Announcement on the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Shenzhen Neptunus Bioengineering: Announcement regarding the risk warnings and remedial measures for dilutive immediate returns of A shares issued to specific parties by the company in 2024 and promises made by related parties.
Shenzhen Neptunus Bioengineering: Announcement of Change in Controlling Shareholder and Actual Controller
Shenzhen Neptunus Bioengineering: Announcement on Progress of Planning Major Matters
